Search

We are urgently seeking Acinetobacter phages for a patient in Belgium. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We are urgently seeking Acinetobacter phages for a patient in Belgium. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

Greg German and colleagues have announced PhageRounds, a global network for phage clinicians and scientists with over 350 members. The group hosts confidential grand rounds and fosters collaboration to advance phage therapy against deadly b

Greg German and colleagues have announced PhageRounds, a global network for phage clinicians and scientists with over 350 members. The group hosts confidential grand rounds and fosters collaboration to advance phage therapy against deadly b

Yangjing Xiong (Shanghai Jiao Tong University) and colleagues published a new paper on phage therapy for ETEC-induced diarrhea, showing phage JE01 reduced ETEC colonization and inflammation in mice, with fluorescent imaging revealing rapid

Hany Ahmed (Tanta University, Egypt) and colleagues published a new paper on isolation and characterization of a lytic phage against carbapenem-resistant A. baumannii (CRAB), showing the phage was effective in treating CRAB lung infections

Cytophage and Winnipeg’s Orthopaedic Innovation Centre announced Manitoba’s first Phage Clinical Treatment Program, initially focused on prosthetic joint infections resistant to antibiotics. The partners planned compassionate-use/N=1 cases

The Innovate UK Phage Innovation Network published a new report on developing phage technologies in the UK, showing the UK has strong phage research but limited translation into real-world solutions across sectors. Key actions include estab

Lorenz Leitner and Shawna McCallin (Balgrist University Hospital) published a new paper on guiding phage therapy with genomic surveillance, showing how integrating global and local genomic data can inform phage cocktail design for a middle

Kinzbio is hiring a Head of Research and Development, to lead to lead their disruptive phage R&D laboratory in Montevideo, Uruguay. In this pivotal role, you will spearhead the design and implementation of cutting-edge research initiatives

University of Sheffield is hiring a PhD student, to study phage infection mechanisms in C. difficile using advanced imaging techniques, aiming to develop effective phage therapies against antibiotic-resistant infections.

New North American phage biology and therapy conference alert! Save the date: Sunday, October 12 to Tuesday, October 14, 2025 at the Washington Hilton Hotel, in Washington, DC.  Organizers: Graham Hatfull, Chip Schooley, Paul Bollyky and

New North American phage biology and therapy conference alert! Save the date: Sunday, October 12 to Tuesday, October 14, 2025 at the Washington Hilton Hotel, in Washington, DC.  Organizers: Graham Hatfull, Chip Schooley, Paul Bollyky and

A historic day for Portugal and phage therapy! A phage therapy framework was approved, allowing magistral preparation of personalized phage products. This was done in part by a petition (inspired by the Belgian phage therapy model) signed b

Bhavya Papudeshi (Flinders University) and colleagues published a new preprint on an automated bioinformatics pipeline for phage therapy candidate screening, showing Sphae can rapidly assess phage safety and suitability for therapeutic use

Baptiste Gaborieau (Université Paris Cité, France) and colleagues created a new machine learning model able to predict Escherichia phage-host interactions and design effective phage cocktails using only genomic data.

Maryn McKenna and Lina Zeldovich held a live Q&A about phage therapy at Emory University. Zeldovich, a Soviet-born scientist-turned-author, discusses her new book "The Living Medicine," which explores the revival of phage therapy as a poten

Marwan Mahmood Saleh (University of Anbar, Iraq) and colleagues evaluated the lytic efficiency of a three-phage cocktail against multidrug-resistant P. aeruginosa isolates in vitro. The cocktail showed broad activity, including against XDR

On 15 November 2024 the board of Portugal's medicines authority INFARMED approved, in Deliberação n.º 112/CD/2024, a guidance note on compounded medicines for phage therapy in hospitals: magistral preparations of bacteriophages made in a ho

University of Liverpool is hiring a PhD student, to study phage therapy delivery strategies for cystic fibrosis lung infections, balancing host responses and therapeutic efficacy.